Drug Trial Radar · NCT00671255
Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia
Last checked: Nov 20, 2026Latest source record: Feb 28, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
829
Actual
Start
Dec 2002
Primary completion
Jan 2004
Study completion Jan 2004
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 5, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This purpose of this study is to evaluate the safety and effectiveness of Ramelteon, once daily (QD), in elderly participants with chronic insomnia.
Conditions
- Chronic Insomnia
Interventions
RamelteonDrug
Ramelteon 4 mg, tablets, orally, once daily for up to 5 weeks.
RamelteonDrug
Ramelteon 8 mg, tablets, orally, once daily for up to 5 weeks.
PlaceboDrug
Ramelteon placebo-matching, tablets, orally, each night for up to 35 consecutive days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Subjective Sleep Latency per subject diary, from Nights 1 through 7 of double-blind TreatmentTime frame: Weeks 1, 2, 3, 4 and 5 or Final Visit.
Locations
115 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Columbiana, Alabama
Site not named
Mobile, Alabama
Site not named
Muscle Shoals, Alabama
Site not named
Tallahassee, Alabama
Site not named
Phoenix, Arizona
Site not named
Scottsdale, Arizona
Site not named
Tempe, Arizona
Site not named
Hot Springs, Arkansas
Site not named
Little Rock, Arkansas
Site not named
Anaheim, California
Site not named
Encinitas, California
Site not named
Irvine, California
Site not named
La Jolla, California
Site not named
La Mesa, California
Site not named
Los Angeles, California
Site not named
Murrieta, California
Site not named
Northridge, California
Site not named
Oakland, California
Site not named
Redlands, California
Site not named
Riverside, California
Site not named
Rosemead, California
Site not named
San Diego, California
Site not named
Spring Valley, California
Site not named
Vista, California
Site not named
Colorado Springs, Colorado
Site not named
Denver, Colorado
Site not named
Clearwater, Florida
Site not named
DeLand, Florida
Site not named
Hollywood, Florida
Site not named
Jacksonville, Florida
Site not named
Kissimmee, Florida
Site not named
Longwood, Florida
Site not named
Pembroke Pines, Florida
Site not named
Pinellas Park, Florida
Site not named
Safety Harbor, Florida
Site not named
St. Petersburg, Florida
Site not named
Tampa, Florida
Site not named
Vero Beach, Florida
Site not named
West Palm Beach, Florida
Site not named
Winter Park, Florida
Showing 40 of 115 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.